The value of sestamibi single-photon emission computed tomography/computed tomography in differentiating and staging renal cell carcinomas: A systematic review.
Publication/Presentation Date
3-1-2022
Abstract
Misdiagnosis of benign renal neoplasms can lead to unnecessary surgical resections, which increases the risk of other morbidities and mortality. Therefore, it is crucial to find a diagnostic modality for differentiation between benign and malignant renal masses. In the current study, we summarized published pieces of evidence concerning the use of technetium-99m (
Volume
16
Issue
1
First Page
32
Last Page
37
ISSN
1661-7649
Published In/Presented At
Deb, A. A., Agag, A., Naushad, N., Krishnamoorthy, R., & Serag, H. (2022). The value of sestamibi single-photon emission computed tomography/computed tomography in differentiating and staging renal cell carcinomas: A systematic review. Current urology, 16(1), 32–37. https://doi.org/10.1097/CU9.0000000000000089
Disciplines
Medicine and Health Sciences
PubMedID
35633856
Department(s)
Department of Surgery
Document Type
Article